Cover Image

PBS newshour. Study shows costly weight loss drug may also cut risks of heart attacks /

Show other versions (9)

The nation's obesity epidemic is growing. Nearly 42 percent of all American adults are considered obese. Now, new findings about the FDA-approved weight-loss drug Wegovy may lead to even more demand for a medication that can be both life-changing and expensive. William Brangham reports.

Bibliographic Details
Other Authors: Brangham, William (Interviewer)
Format: Video
Language:English
Language Notes:In English.
Published: Arlington, VA : NewsHour Productions, 2023.
Series:Academic Video Online
Subjects:
Obesity > United States.
Drugs.
Weight loss.
Heart > Disease.
Obésité > États-Unis.
Médicaments.
Perte de poids.
Obesity.
United States.
Television news programs.
Téléjournaux.
Online Access:Connect to this streaming video (Alexander Street Press)
Description
Summary:The nation's obesity epidemic is growing. Nearly 42 percent of all American adults are considered obese. Now, new findings about the FDA-approved weight-loss drug Wegovy may lead to even more demand for a medication that can be both life-changing and expensive. William Brangham reports.
Physical Description:1 online resource (7 minutes)
Playing Time:00:06:38